This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
2024 Dates to be Announced

BOKO Therapeutics Inc.


Company Description

BOKO Therapeutics Inc., founded in March 2022, is an immuno-oncology company based on pioneering work from MD Anderson. BOKO focuses on developing novel cancer therapeutics for solid tumors. The company believes its novel approach to empowering patients' innate and adaptive immune responses against cancer will play a leading role in the successful treatment of solid tumors. The company initially focuses on oncogene-driven solid tumors of unmet need, including lung, pancreatic, and CRC cancers.